Anders Carlson, MD
Endocrinology, Diabetes & Metabolism · St Louis Park, MNNPI 1720254725
Payments from drug & device makers
Across 667 payments — averaging $8379.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3.2M
- Insulet Corporation$1.5M
- Eli Lilly$271K
- Sequel Med Tech, LLC$196K
- Novo Nordisk AS$169K
- Tandem Diabetes Care, Inc.$104K
- plus $164K from 12 others
Across 1 payment — averaging $922.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$923
What the payments were for
- Consulting fees$53,76133%
- Speaking & faculty fees$87,07853%
- Travel & lodging$17,67811%
- Food & beverage$4,3363%
- Gifts$430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 226 | $3,178,322 |
| Insulet Corporation | 67 | $1,506,376 |
| Eli Lilly | 29 | $270,847 |
| Sequel Med Tech, LLC | 184 | $196,116 |
| Novo Nordisk AS | 88 | $169,330 |
| Tandem Diabetes Care, Inc. | 1 | $103,924 |
| Abbott | 22 | $67,601 |
| Dexcom, Inc. | 8 | $53,104 |
| Novo Nordisk | 12 | $19,298 |
| Mannkind Corporation | 18 | $10,089 |
| Amgen | 1 | $6,269 |
| Zealand Pharma A/s | 2 | $3,560 |
| Lilly USA, LLC | 1 | $1,575 |
| Ascensia Diabetes Care US Inc. | 1 | $1,500 |
| Sanofi-aventis U.S. LLC | 3 | $720 |
| Companion Medical, Inc. | 1 | $500 |
| Polarityte, Inc. | 2 | $122 |
| Senseonics, Incorporated | 1 | $53 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InPen$17,500
- Omnipod$14,457
- Minimed 670G System$10,326
- AFREZZA$9,583
- Tresiba$8,160
- Minimed 770G System$4,200
- MINIMED 780G$1,492
- TOUJEO$720
- Saxenda$716
- DEXCOM G6 TRANSMITTER$225
- SkinTE$102
How this compares
$5,589,306 in reported general payments places this provider in the 95th percentile of 120 endocrinology, diabetes & metabolism providers in Minnesota.
See all endocrinology, diabetes & metabolism providers in Minnesota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in St Louis Park
- Richard BergenstalSt Louis Park$4M
- Haleigh JamesSt Louis Park$1.1M
- Laura LafaveSt Louis Park$1K
- Irina BancosRochester$4.8M
- Yogish KudvaRochester$2.9M
- Marius StanRochester$2.2M
- John MorrisRochester$1.9M
- Adrian VellaRochester$1.7M
- Mabel RyderRochester$691K
- Maria CaramoriMinneapolis$685K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.